Paclitaxel Fresenius Kabi

Paclitaxel, the active ingredient in Paclitaxel Fresenius Kabi, is a taxane presented as a sterile injectable solution for intravenous use. It is employed in the treatment of various solid tumours and is administered under the supervision of oncology specialists. GNH USA supplies Paclitaxel Fresenius Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres, hospitals and pharmacies worldwide.

GNH USA supplies Paclitaxel Fresenius Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres, hospitals and pharmacies worldwide.

Paclitaxel is a chemotherapy agent that interferes with cell division in a range of solid tumours.

- Breast cancer: improves the overall response rate in combination with other chemotherapeutics. - Non‑small cell lung cancer: used as a first‑line or maintenance therapy for patients with advanced disease. - Ovarian cancer: administered as adjuvant treatment to reduce the risk of recurrence. - Gastric ​ ​  ​  ​  ​  ​  ​  ​  ​   ​  ​  ​  ​  ​  ​  ​ ​ ​-   -   -  

The